Christine leads the commercial (business development & marketing) organization at NDA Group. Her passion over her 25+ years in and around life sciences is making an impact on patients' lives by helping bio/pharma companies be successful in achieving their missions. She has strategic and operational experience in the healthcare sector broadly (bio/pharma, medtech, consumer, and services) both internally and as an advisor, with a proven track record of successful external business transactions, and team leadership and development.
Key Areas Of Expertise
- Executive leadership
- Business strategy
- Licensing and M&A
- Financing
Before NDA
Christine has held CEO and executive level business development, communications and strategy positions at biotech companies, including BioArctic, Medivir and LifeCell after a decade-long career as an investment banker at Merrill Lynch advising biotech and pharma companies on licensing, M&A and financing.
